Ferran Nadeu
Grup de recerca
- Patologia molecular en neoplàsies limfoides Post-doctoral researcher (R2A)
Publicacions destacades
-
Molecular map of chronic lymphocytic leukemia and its impact on outcome
Autors:Referència: Nature Genetics 2022. -
Detection of early seeding of Richter transformation in chronic lymphocytic leukemia
Autors:Referència: Nature Medicine 2022. -
IGLV3-21R110 identifies an aggressive biological subtype of chronic lymphocytic leukemia with intermediate epigenetics
Autors:Referència: Blood 2021. -
Genomic and epigenomic insights into the origin, pathogenesis and clinical behavior of mantle cell lymphoma subtypes
Autors:Referència: Blood 2020. -
IgCaller for reconstructing immunoglobulin gene rearrangements and oncogenic translocations from whole-genome sequencing in lymphoid neoplasms
Autors:Referència: Nature Communications 2020. -
Genomic and Epigenomic Alterations in Chronic Lymphocytic Leukemia
Autors:Referència: Annual Review Of Pathology-Mechanisms Of Disease 2020. -
Clinical impact of the subclonal architecture and mutational complexity in chronic lymphocytic leukemia
Autors:Referència: Leukemia 2018. -
Clinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1, and ATM mutations in chronic lymphocytic leukemia
Autors:Referència: Blood 2016.
Projectes destacats
-
Tracking the origin of chronic lymphocytic leukemia progression and transformation through its genomic and transcriptomic footprints
Investigador/a principal: Ferran Nadeu PratFinançador: European Hematology Association (EHA)Codi: EHA Junior Research Grant 2021 (RG-202012-00245)Durada: 01/01/2022 - 31/12/2024 -
Tracking the origin of chronic lymphocytic leukemia progression and transformation through its genomic and transcriptomic footprints
Investigador/a principal: Ferran Nadeu PratFinançador: Lady Tata Memorial TrustCodi: International Award for Research in Leukaemia 2021-2022 (LADY_TATA_21_3223)Durada: 01/10/2021 - 30/09/2022 -
Tracking the progression and transformation of chronic lymphocytic leukemia
Investigador/a principal: Ferran Nadeu PratFinançador: American Association for Cancer Research (AACR)Codi: American Association for Cancer Research (AACR)-Amgen Fellowship in Clinical/Translational Cancer Research (21-40-11-NADE)Durada: 01/07/2021 - 30/06/2023